Table 4. Kaplan-Meyer analysis of survival.
Overall Survival | Progression free survival | |||||||
Variables | Median OS | Median OS | Chi- | p | Median PFS | Median PFS | Chi- | p |
Altered levels | Normal levels | square | Altered levels | Normal Levels | square | |||
CECs>20 cells/mL | 8 | 11 (8.9–13) | 0.52 | 0.5 | 9 (6–11) | 10 (7.9–12) | 0.64 | 0.4 |
MPs>3278 MP/µL | 16 | 10 (6.1–13.8) | 4.3 | 0.04 | 15(11.4–18) | 9 (8–12) | 4.02 | 0.04 |
ETG>275 nMol | 7(0.11–13.8) | 11 (6.6–15.3) | 0.05 | 0.8 | 6 (0–14) | 11 | 1.5 | 0.2 |
OS and PFS in patients according to pre-treatment marker levels (compared to 99th percentile of controls).The upper reference limit levels of parameters were calculated as values higher than the 99th percentile of the control group (healthy subjects) and were set at: CECs = 20 cells/L; MPs = 3278 MP/µL; ETG = 275 mM. CEC, circulating endothelial cells; MPs, microparticles; ETG, endogenous thrombin generation.